Here, we summarize the results from the INCREASE study, originally published in the New England Journal of Medicine. The INCREASE study looked at how well a medication called inhaled treprostinil works and how safe it is, compared to placebo (a fake medication), in adults who have pulmonary hypertension associated with interstitial lung disease or PH-ILD.This is a Plain Language Summary of Publication article published in Future Cardiology. This article summarises the results of a study called INCREASE which looked at how effective and safe a medication called inhaled treprostinil is in adults who have pulmonary hypertension associated with interstitial lung disease (PH-ILD).

You can read the full article here.

The original article on which this summary is based is called ‘Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease’. It was published in The New England Journal of Medicine. 

You can read the original article here.